{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:29:19Z","timestamp":1791570559045,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Australian Government Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.antiviral.2022.105280","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T12:44:02Z","timestamp":1647348242000},"page":"105280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Characterization of influenza B viruses with reduced susceptibility to influenza neuraminidase inhibitors"],"prefix":"10.1016","volume":"200","author":[{"given":"Sook Kwan","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeu-Yang","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Baz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian G.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2022.105280_bib1","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/508777","article-title":"Characterization of multidrug-resistant influenza A\/H3N2 viruses shed during 1 year by an immunocompromised child","volume":"43","author":"Baz","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105280_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222381","article-title":"The epidemiological signature of influenza B virus and its B\/Victoria and B\/Yamagata lineages in the 21st century","volume":"14","author":"Caini","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2022.105280_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00239-008-9119-z","article-title":"The evolutionary dynamics of human influenza B virus","volume":"66","author":"Chen","year":"2008","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.antiviral.2022.105280_bib4","first-page":"73","article-title":"[Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza]","volume":"148","author":"de Jong","year":"2004","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"10.1016\/j.antiviral.2022.105280_bib5","doi-asserted-by":"crossref","first-page":"8387","DOI":"10.1016\/j.vaccine.2020.10.074","article-title":"Influenza vaccine effectiveness against laboratory-confirmed influenza in a vaccine-mismatched influenza B-dominant season","volume":"38","author":"Drori","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2022.105280_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2017.08.004","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016","volume":"146","author":"Gubareva","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.antiviral.2022.105280_bib7","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1093\/bioinformatics\/bty407","article-title":"Nextstrain: real-time tracking of pathogen evolution","volume":"34","author":"Hadfield","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.antiviral.2022.105280_bib8","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1073\/pnas.172393399","article-title":"Rescue of influenza B virus from eight plasmids","volume":"99","author":"Hoffmann","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2022.105280_bib9","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.23.19884-en","article-title":"Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation","volume":"16","author":"Hurt","year":"2011","journal-title":"Euro Surveill"},{"key":"10.1016\/j.antiviral.2022.105280_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.antiviral.2016.06.001","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015","volume":"132","author":"Hurt","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105280_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jiac.2019.04.007","article-title":"In vitro neuraminidase inhibitory concentration (IC(50)) of four neuraminidase inhibitors in the Japanese 2017-18 season: comparison with the 2010-11 to 2016-17 seasons","volume":"25","author":"Ikematsu","year":"2019","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.antiviral.2022.105280_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jiac.2018.01.013","article-title":"Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in Japan","volume":"24","author":"Ishiguro","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.antiviral.2022.105280_bib13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/597360","article-title":"Comparison of the effectiveness of zanamivir and oseltamivir against influenza A\/H1N1, A\/H3N2, and B","volume":"48","author":"Kawai","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105280_bib14","series-title":"Animal Influenza Virus: Methods and Protocols","first-page":"3","article-title":"Hemagglutination assay for influenza virus","author":"Killian","year":"2020"},{"issue":"5","key":"10.1016\/j.antiviral.2022.105280_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11262-021-01853-w","article-title":"Genetic characterisation of the influenza viruses circulating in Bulgaria during the 2019-2020 winter season","volume":"57","author":"Korsun","year":"2021","journal-title":"Virus Gene."},{"key":"10.1016\/j.antiviral.2022.105280_bib16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jfma.2016.01.017","article-title":"Circulating pattern and genomic characteristics of influenza B viruses in Taiwan from 2003 to 2014","volume":"115","author":"Kuo","year":"2016","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.antiviral.2022.105280_bib17","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/infdis\/jiv288","article-title":"E119D neuraminidase mutation conferring pan-resistance to neuraminidase inhibitors in an A(H1N1)pdm09 isolate from a stem-cell transplant recipient","volume":"212","author":"L'Huillier","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105280_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.antiviral.2018.07.001","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017","volume":"157","author":"Lackenby","year":"2018","journal-title":"Antivir. Res."},{"issue":"122","key":"10.1016\/j.antiviral.2022.105280_bib19","first-page":"55570","article-title":"Fluorescence-based neuraminidase inhibition assay to assess the susceptibility of influenza viruses to the neuraminidase inhibitor class of antivirals","author":"Leang","year":"2017","journal-title":"JoVE\u202f: JoVE"},{"key":"10.1016\/j.antiviral.2022.105280_bib20","volume":"vol. 20","author":"Little","year":"2015"},{"key":"10.1016\/j.antiviral.2022.105280_bib21","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/irv.12862","article-title":"Oseltamivir treatment of influenza A and B infections in infants","volume":"15","author":"Mattila","year":"2021","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.antiviral.2022.105280_bib22","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.1128\/JVI.78.23.12817-12828.2004","article-title":"Multiple genotypes of influenza B virus circulated between 1979 and 2003","volume":"78","author":"McCullers","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105280_bib23","first-page":"369","article-title":"Working group on surveillance of influenza antiviral susceptibility \u2013 Geneva, November 2011 and June 2012","volume":"87","year":"2012","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.antiviral.2022.105280_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2014.07.001","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013","volume":"110","author":"Meijer","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105280_bib25","doi-asserted-by":"crossref","first-page":"104895","DOI":"10.1016\/j.antiviral.2020.104895","article-title":"Substitutions at H134 and in the 430-loop region in influenza B neuraminidases can confer reduced susceptibility to multiple neuraminidase inhibitors","volume":"182","author":"Mohr","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105280_bib26","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/bioinformatics\/bty121","article-title":"Parallelization of MAFFT for large-scale multiple sequence alignments","volume":"34","author":"Nakamura","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.antiviral.2022.105280_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.antiviral.2012.01.006","article-title":"Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States","volume":"93","author":"Nguyen","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105280_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.antiviral.2018.10.008","article-title":"In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit","volume":"160","author":"Noshi","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105280_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/irv.12215","article-title":"Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria","volume":"8","author":"Okomo-Adhiambo","year":"2014","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.antiviral.2022.105280_bib30","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/bioinformatics\/bts091","article-title":"Unipro UGENE: a unified bioinformatics toolkit","volume":"28","author":"Okonechnikov","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.antiviral.2022.105280_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/infdis\/jiq010","article-title":"Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors","volume":"203","author":"Pizzorno","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105280_bib32","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.1128\/JVI.79.13.8431-8439.2005","article-title":"Attenuation of equine influenza viruses through truncations of the NS1 protein","volume":"79","author":"Quinlivan","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105280_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8040591","article-title":"Epidemiology and genetic Variability of circulating influenza B viruses in Uruguay, 2012-2019","volume":"8","author":"Rivas","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.antiviral.2022.105280_bib34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/irv.12714","article-title":"Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: a season of B lineage mismatched to the trivalent vaccine","volume":"14","author":"Rose","year":"2020","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.antiviral.2022.105280_bib35","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1186\/s12879-020-05670-8","article-title":"Clinical characteristics and outcomes of influenza A and B virus infection in adult Australian hospitalised patients","volume":"20","author":"Sharma","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105280_bib36","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/cid\/ciy876","article-title":"Vaccine effectiveness against lineage-matched and -mismatched influenza B viruses across 8 seasons in Canada, 2010-2011 to 2017-2018","volume":"68","author":"Skowronski","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105280_bib37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41598-020-80895-w","article-title":"Characterizing genetic and antigenic divergence from vaccine strain of influenza A and B viruses circulating in Thailand, 2017-2020","volume":"11","author":"Suntronwong","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2022.105280_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2015.02.003","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014","volume":"117","author":"Takashita","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105280_bib39","doi-asserted-by":"crossref","first-page":"104718","DOI":"10.1016\/j.antiviral.2020.104718","article-title":"Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018","volume":"175","author":"Takashita","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105280_bib40","first-page":"725","volume":"vol. 9","author":"Takashita","year":"2020"},{"key":"10.1016\/j.antiviral.2022.105280_bib41","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/infdis\/jiv245","article-title":"Emergence of multidrug-resistant influenza A(H1N1)pdm09 virus variants in an immunocompromised child treated with oseltamivir and zanamivir","volume":"212","author":"Tamura","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105280_bib42","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05055","article-title":"The contrasting phylodynamics of human influenza B viruses","volume":"4","author":"Vijaykrishna","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.antiviral.2022.105280_bib43","series-title":"Encyclopedia of Virology","first-page":"561","article-title":"Influenza B, C and D viruses (Orthomyxoviridae)","author":"Wolff","year":"2021"},{"key":"10.1016\/j.antiviral.2022.105280_bib44","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12859-015-0749-z","article-title":"DECIPHER: harnessing local sequence context to improve protein multiple sequence alignment","volume":"16","author":"Wright","year":"2015","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.antiviral.2022.105280_bib45","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3389\/fmicb.2020.01079","article-title":"Characterization of influenza A and B viruses circulating in southern China during the 2017-2018 season","volume":"11","author":"Yan","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2022.105280_bib46","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/JCM.03265-13","article-title":"Universal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics","volume":"52","author":"Zhou","year":"2014","journal-title":"J. Clin. Microbiol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222000481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222000481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:35:58Z","timestamp":1759062958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354222000481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":46,"alternative-id":["S0166354222000481"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105280","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of influenza B viruses with reduced susceptibility to influenza neuraminidase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105280"}}